Malantide TFA Catalog No.:M11753-10 CN1CCN(CC1)C(=O)CN[C@@H]1C[C@H]1C1C=CC(=CC=1)OCC1C=CC=CC=1 |&1:13

CN1CCN(CC1)C(=O)CN[C@@H]1C[C@H]1C1C=CC(=CC=1)OCC1C=CC=CC=1 |&1:13

It has no activity at other histone methyltransferases

Smiles: CN([C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1CCCC2=CC=CC=C21)NC(=O)COCCOCCOCCOCCOCCN)C(=O)OC(C)(C)C

loganin increases cell viability

13(5):e0197406

Malantide TFA Catalog No.:M11753-10 CN1CCN(CC1)C(=O)CN[C@@H]1C[C@H]1C1C=CC(=CC=1)OCC1C=CC=CC=1 |&1:13Malantide TFA is a synthetic dodecapeptide derived from the site phosphorylated by cAMP dependent protein kinase (PKA) on the subunit of phosphorylase kinase. Malantide TFA is a highly specific substrate for PKA with a Km of 15 M and shows protein inhibitor (PKI) inhibition >90% substrate phosphorylation in various rat tissue extracts. Malantide TFA is also an efficient substrate for PKC with a Km of 16 M. Product information Molecular Weight: 1747.